Navigation Links
Freudenberg Reports Third Year of Sales Growth in 2012
Date:4/23/2013

PLYMOUTH, Mich., April 23, 2013 /PRNewswire/ -- Freudenberg, a global, family-owned group of companies, grew sales for the third year in a row. In 2012 sales amounted to EUR 6.322 billion (USD 8.2 billion), the highest in the Company's history, and 5.5 percent higher than 2011. Sales in North America grew by almost 19 percent to EUR 1.4 billion (USD 1.8 billion).

"Freudenberg successfully held its ground in a particularly challenging market environment and achieved strong and profitable growth in many areas. Our broadly diversified product portfolio and our global presence are the foundation for our success," Dr. Mohsen Sohi , Speaker of the Board of Management of the Freudenberg Group, said in the annual press conference in Weinheim, Germany. "Freudenberg was able to grow sales further thanks to innovative products, a high degree of customer orientation and flexibility as well as structured and sustainable expansion in growth markets."

Although the financial and debt crises impacted business in markets in Southern Europe, the decline was offset by growth in the BRIC countries and in North America.

"Across the board, all Freudenberg companies in North America had a good year, reporting better profits in 2012 than in previous years. Overall, operating results for the Region improved by 26 percent. That is extremely important because North America, Freudenberg's second largest market, currently generates 21 percent of total Freudenberg sales," said Leesa Smith , Freudenberg North America president and regional representative. "Increased automotive sales played an important role in achieving improved 2012 results."

Employment rose to 7,739 in North America compared to 6
'/>"/>

SOURCE Freudenberg Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Danaher Reports Record First Quarter 2013 Results
2. Quest Diagnostics Reports First Quarter 2013 Financial Results
3. Synthetic Biologics Reports Year End 2012 Financial Results
4. CPhI and PharmaEvolution.com to Analyze Pharma Industry in Monthly and Annual Reports
5. Medical Marijuana, Inc. Reports Record First Quarter 2013 Revenue and Income
6. Cardium Announces $4.0 Million Preferred Stock Financing And Reports On Exchange Listing Compliance
7. VG Life Sciences Reports Positive Safety Results from Second Cohort Enrollment in Solid Tumor Clinical Trial
8. Inovio Collaborator ChronTech Reports Interim Phase II Clinical Study Results from ChronVac-C Vaccine for Hepatitis C Infection
9. Two New Strategic Reports Expand Coverage Of BioTrends Biosimilars Advisory Service
10. ULURU Inc. Reports Financial Results For Fourth Quarter And Year Ending December 31, 2012
11. Consumer Reports: So Many Drugstores, So Many Prices; New Report Finds Price Mayhem At The Pharmacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... , Oct. 20, 2014  ResMed (NYSE: ... of the ResMed Data Exchange program, a comprehensive ... medical equipment (HME) and other health care providers. ... secure access to critical patient information. It integrates ... AirView™ and U-Sleep™ patient management platforms with customers, ...
(Date:10/20/2014)... PRINCETON, N.J. , Oct. 20, 2014 /PRNewswire/ ... Taiho Pharmaceutical Co., Ltd. ( Japan ... Administration (FDA) granted Fast Track designation for TAS-102 ... combination anticancer drug under investigation for the treatment ... the Company has initiated a rolling NDA submission ...
(Date:10/20/2014)... October 20, 2014 Norgine B.V. ... novel, low volume bowel preparation, NER1006, presented at the ... College of Gastroenterology (ACG), Philadelphia, PA ... stool weight and co-primary endpoint of cleansing success. The ... vs. MOVIPREP ® in screening colonoscopy patients. [1] ...
Breaking Medicine Technology:ResMed Launches ResMed Data Exchange 2Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 2Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 3Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 4Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 2
... Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) will ... Tuesday, February 15, 2011.  The presentation is scheduled for ... through the Company,s web site, www.regeneron.com , on ... presentation will be available after the live webcast through ...
... Feb. 8, 2011 IPC The Hospitalist Company, Inc. (Nasdaq: ... practice company, announced today that it will report results for ... Monday, March 7, 2011, after the market close. ... 5:00 p.m. ET (2:00 p.m. PT) on March 7, 2011 ...
Cached Medicine Technology:IPC The Hospitalist Company, Inc. to Report Fourth Quarter 2010 Results 2
(Date:10/20/2014)... 2014 The Advocator Group, LLC ... the American Foundation for Suicide Prevention’s (AFSP) Out of ... a not-for-profit organization that hosts hundreds of community walks ... events are used to help understand and prevent suicide ... relationships as well. , The Advocator Group shares ...
(Date:10/20/2014)... Indianapolis, IN (PRWEB) October 20, 2014 ... Quick Start, a secure cloud solution that enables ... advantage of the ultimate healthcare-specific customer relationship management ... to meet the unique needs of the healthcare ... healthcare experience for providers and patients by combining ...
(Date:10/20/2014)... 20, 2014 Principle Business Enterprises, a ... in manufacturing top-of-the-line absorbent products. The company has ... most popular brand, Tranquility® Premium Protection absorbent products. ... website, gave its packaging a new look, and is ... message to the public. , The new website, developed ...
(Date:10/20/2014)... 2014 Succeed is proud to announce that ... participated in the Every Body Walk! campaign by ... project that encourages workers to be more active outside of ... which concluded at the end of September, was a friendly ... metro areas. Participating companies gave their staff pedometers and ...
(Date:10/20/2014)... Unveiled at the Sept. 18 board meeting, ... estimates member hospital ROI on membership dues at 12.5. In ... provides $12.50 in value to member hospitals. The calculation used ... Dues)/Member Dues. , “This is the first time we’ve ... think the methodology is really sound,” said Bill Ryan ...
Breaking Medicine News(10 mins):Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4
... and growth hormone expert from University Hospitals Rainbow Babies and ... New England Journal of Medicine commenting on a ... doses of estrogen, as well as growth hormone, years before ... benefits. With her co-author Dr. Robert L. Rosenfield, ...
... need to proactively engage lesbian, gay, bisexual, and transgender ... populations to identify and better understand health conditions that ... of Medicine. The scarcity of research yields an ... is further fragmented by the tendency to treat sexual ...
... life-threatening bloodstream infections in children with peripherally inserted central ... removing the device as early as possible, according to ... March 31 in the journal Clinical Infectious Diseases ... Saturday, April 2, at the annual meeting of the ...
... News) -- In an update to its ongoing radiation ... U.S. government officials announced late Wednesday that milk sampled ... radiation not likely to cause harm to humans. ... and Drug Administration and the Environmental Protection Agency, the ...
... field continues to grow. Following the successful First ... the Second International Conference on Immune Tolerance will ... research and insights into the mechanisms and treatment ... diseases, inflammation and cancer. This Conference is supported ...
... to a riddle or understand the solution to a problem, ... our head. But what happens after the ,Aha!, moment? Why ... stick in our memory? ,Much of memory research involves ... the group of Prof. Yadin Dudai of the Institute,s Neurobiology ...
Cached Medicine News:Health News:Assessing the value of treatments to increase height 2Health News:Researchers need to engage lesbian, gay, bisexual, and transginder populations in health studies 2Health News:Remove children's catheters as soon as possible to prevent bloodstream infections 2Health News:2nd International Conference on Immune Tolerance 2Health News:Getting a grasp on memory 2
... Farnsworth panel D15 test evaluation has ... to arrange caps with automatic creation ... manual color deficiency analysis, calculation of ... age-corrected CCI, eye selection (OD, OS, ...
... test is used to separate ... vs normal. Farnsworth D15 come ... the patient to select the ... box is closed and the ...
HRR/Amsler book combo with occluding glasses....
Ishihara test chart book for color blindness. 14 plate. A simple accurate method for discovering congenital color blindness....
Medicine Products: